Biophytis SA

ALBPS

Company Profile

  • Business description

    Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

  • Contact

    BC 9, Batiment A 4eme etage
    4 pace Jussieu
    Sorbonne University
    Paris75005
    FRA

    T: +33 144272300

    https://www.biophytis.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    24

Stocks News & Analysis

stocks

New ASX share on our best ideas list

This undervalued miner is unappreciated by the market.
stocks

Has the most hated company on the ASX 200 bounced back?

Encouraging results indicate a potential turnaround story.
stocks

Amazon earnings: Good results, with AWS still a winner; fear on profitability guidance is overblown

We think Amazon stock looks attractive.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,922.0077.00-0.86%
CAC 407,546.16225.81-2.91%
DAX 4023,425.97639.50-2.66%
Dow JONES (US)43,588.58542.40-1.23%
FTSE 1009,068.5864.23-0.70%
HKSE24,682.6490.69-0.37%
NASDAQ20,650.13472.31-2.24%
Nikkei 22540,290.70779.12-1.90%
NZX 50 Index12,684.04139.70-1.09%
S&P 5006,238.01101.38-1.60%
S&P/ASX 2008,663.7079.10-0.90%
SSE Composite Index3,579.2719.320.54%

Market Movers